9.1.11 TISSUE ACQUISITION AND CELLULAR/MOLECULAR SHARED SERVICE The Tissue Acquistion and Cellular/Molecular Analysis Shared Service (TACMASS) performs two main functions for the Arizona Cancer Center (AZCC): 1. Tissue Acquisition: TACMASS cpilects, preserves, and banks biospecimens obtained from consented AZCC surgical patients. Banked bibspeciniens (frozen and formalin fixed, paraffin embedded tissues, genomic DNA, plasma, serum and urine) are annotated with clinical and pathological infomiation, which enables investigators to query a database to identify appropriate biospecimens that may be useful for analysis under University of Arizona Institutional Review Board (IRB) approved protocols. The overall goal is to provide cancer researchers with access to a repository of high quality, carefully collected and annotated human tumor tissue and body fluids for current and future translational studies in cancer. 2. Molecular and pathological analysis of tissues and cells: TACMASS provides AZCC researchers with access to state of the art molecular analytical tools using techniques of routine histology, immunohistochemistry. Laser Capture Microdissection, and the construction of Tissue Microarrays. TACMASS assists researchers with experimental design and the establishment of histological scoring strategies, and consults with investigators to analyze and interpret pathological findings in the overall context of the whole project. One ofthe primary goals of TACMASS is to provide AZCC researchers from all five programs with high quality pathological analysis and interpretation of experimental data. The Service is directed by Ray Nagle, M.D., Ph.D. Co-Directors are Achyut Bhattacharyya M.D. and Wenxin Zheng, M.D. The service is staffed with four research specialists.

Public Health Relevance

This service focuses on the collection, preservation and interrogation of human and experimental animal tissues and cells. TACjVIASS is an essential element in translational research and the advancement of Arizona Cancer Center efforts to prevent and cure cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA023074-31
Application #
7944576
Study Section
Subcommittee G - Education (NCI)
Project Start
2009-08-19
Project End
2014-06-30
Budget Start
2009-08-19
Budget End
2010-06-30
Support Year
31
Fiscal Year
2009
Total Cost
$177,870
Indirect Cost
Name
University of Arizona
Department
Type
DUNS #
806345617
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Knudsen, Erik S; Balaji, Uthra; Mannakee, Brian et al. (2018) Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility. Gut 67:508-520
Boese, Cody J; Nye, Jonathan; Buster, Daniel W et al. (2018) Asterless is a Polo-like kinase 4 substrate that both activates and inhibits kinase activity depending on its phosphorylation state. Mol Biol Cell 29:2874-2886
Sohail, Atif; Mushtaq, Adeela; Iftikhar, Ahmad et al. (2018) Emerging immune targets for the treatment of multiple myeloma. Immunotherapy 10:265-282
Doane, Cynthia J; Patil, Karuna; Hoffman, Emely A et al. (2018) Supernumerary Incisors in CB6F1 Mice Conditioned with Chemotherapy and Total Body Irradiation before Bone Marrow Transplantation. Comp Med 68:349-352
Bea, J W; Hsu, C-H; Blew, R M et al. (2018) Use of iDXA spine scans to evaluate total and visceral abdominal fat. Am J Hum Biol 30:
Lent, Adrienne B; O'Connor, Patrick A; Reikowsky, Ryan C et al. (2018) Quit outcomes among clients ineligible for cessation medication through the state quitline: a retrospective, observational study. BMC Public Health 18:1001
Bulkley, Joanna E; McMullen, Carmit K; Grant, Marcia et al. (2018) Ongoing ostomy self-care challenges of long-term rectal cancer survivors. Support Care Cancer 26:3933-3939
Zaim, Samir Rachid; Li, Qike; Schissler, A Grant et al. (2018) Emergence of pathway-level composite biomarkers from converging gene set signals of heterogeneous transcriptomic responses. Pac Symp Biocomput 23:484-495
Kobes, Joseph E; Georgiev, George I; Louis, Anthony V et al. (2018) A Comparison of Iron Oxide Particles and Silica Particles for Tracking Organ Recellularization. Mol Imaging 17:1536012118787322
Kelly, K R; Espitia, C M; Zhao, W et al. (2018) Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy. Leukemia 32:230-233

Showing the most recent 10 out of 1336 publications